{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:35:43Z","timestamp":1788975343130,"version":"build-2803163510"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001774","name":"The University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Kidney transplantation is usually the optimal treatment option for patients living with kidney failure given its associations with improved survival, quality of life outcomes and a reduction in the personal, economic, and societal burden of long-term dialysis. While advantages of kidney transplantation are recognized, post-transplant complications, such as graft rejection, ischemia\u2013reperfusion injury, surgical-related complications, and long-term consequences of immunosuppressive therapies, are commonly observed. There has been increased research on developing non-invasive biomarkers for the monitoring of transplanted kidneys over recent decades. The potential of urinary biomarkers to identify graft rejection, post-transplant acute tubular necrosis, detect progression of epithelial-to-mesenchymal transition toward tubulointerstitial fibrosis, and to differentiate between causes of graft dysfunction is an attractive alternative to invasive transplant biopsy. Innovative urinary biomarkers, such as those derived from omics technologies allow for a more holistic assessment of graft status through multi-parametric molecular analysis, although there remain questions on the consistency, reliability, and practicality of utilizing omics-based urinary biomarkers. The international nephrology community has continued to make concerted efforts to improve the procedures and cost-effectiveness of kidney transplant monitoring. In this article, we review the evidence and limitations of currently available urinary biomarkers and propose the application of urine-derived exfoliated kidney cells such as urinary exfoliated proximal tubule cells to prognosticate kidney transplant outcomes and monitor for post-transplant complications. Artificial intelligence and the incorporation of machine learning analysis of proximal tubular cell characteristics may optimize the process of differentiating graft rejection from other forms of kidney dysfunction non-invasively following kidney transplantation.<\/jats:p>","DOI":"10.1007\/s10157-026-02827-8","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:04:39Z","timestamp":1770649479000},"page":"835-846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exfoliated kidney cells from urine for non-invasive kidney transplant monitoring: A potential opportunity?"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4561-0844","authenticated-orcid":false,"given":"Henry H. L.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen Kumar","family":"Parthiban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa M.","family":"Goldys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2827_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60202-5","volume":"379","author":"GG Garcia","year":"2012","unstructured":"Garcia GG, Harden P, Chapman J. The global role of kidney transplantation. Lancet. 2012;379:e36-8.","journal-title":"Lancet"},{"key":"2827_CR2","unstructured":"Australian and New Zealand Dialysis and Transplant Registry. ANZDATA 43rd Annual Report 2020. ANZDATA Registry. Adelaide, SA; 2020."},{"key":"2827_CR3","unstructured":"Australian and New Zealand Dialysis and Transplant Registry. ANZDATA 46th Annual Report 2024. ANZDATA Registry. Adelaide, SA; 2024."},{"key":"2827_CR4","first-page":"587","volume":"14","author":"M Haberal","year":"2016","unstructured":"Haberal M, Boyvat F, Akdur A, K\u0131rnap M, \u00d6z\u00e7elik \u00dc. Surgical complications after kidney transplantation. Exp Clin Transplant. 2016;14:587\u201395.","journal-title":"Exp Clin Transplant"},{"key":"2827_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1432-2277.2004.00019.x","volume":"18","author":"AD Kirk","year":"2005","unstructured":"Kirk AD, Mannon RB, John Swanson S, Hale DA. Strategies for minimizing immunosuppression in kidney transplantation. Transplant Int. 2005;18:2\u201314.","journal-title":"Transplant Int"},{"key":"2827_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","volume":"12","author":"J Sellar\u00e9s","year":"2012","unstructured":"Sellar\u00e9s J, De Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12:388\u201399.","journal-title":"Am J Transplant"},{"key":"2827_CR7","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","volume":"104","author":"SJ Chadban","year":"2020","unstructured":"Chadban SJ, Ahn C, Axelrod DA, et al. KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation. 2020;104:S11-103.","journal-title":"Transplantation"},{"key":"2827_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/j.ajkd.2012.02.330","volume":"60","author":"KM Corapi","year":"2012","unstructured":"Corapi KM, Chen JL, Balk EM, Gordon CE. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis. 2012;60:62\u201373.","journal-title":"Am J Kidney Dis"},{"key":"2827_CR9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2215\/CJN.04710420","volume":"15","author":"ED Poggio","year":"2020","unstructured":"Poggio ED, McClelland RL, Blank KN, et al. Systematic review and meta-analysis of native kidney biopsy complications. Clin J Am Soc Nephrol. 2020;15:1595\u2013602.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2827_CR10","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/ckj\/sfy051","volume":"11","author":"WL Whittier","year":"2018","unstructured":"Whittier WL, Gashti C, Saltzberg S, Korbet S. Comparison of native and transplant kidney biopsies: diagnostic yield and complications. Clin Kidney J. 2018;11:616\u201322.","journal-title":"Clin Kidney J"},{"key":"2827_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2215\/CJN.03380318","volume":"13","author":"SJ Gilbert","year":"2018","unstructured":"Gilbert SJ. Does the kidney biopsy portend the future of nephrology? Clin J Am Soc Nephrol. 2018;13:681\u20132.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2827_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13220","volume":"72","author":"F Jamshaid","year":"2018","unstructured":"Jamshaid F, Froghi S, Di Cocco P, Dor FJ. Novel non\u2010invasive biomarkers diagnostic of acute rejection in renal transplant recipients: a systematic review. Int J Clin Pract. 2018;72:e13220.","journal-title":"Int J Clin Pract"},{"key":"2827_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00345-007-0211-6","volume":"25","author":"W Gwinner","year":"2007","unstructured":"Gwinner W. Renal transplant rejection markers. World J Urol. 2007;25:445\u201355.","journal-title":"World J Urol"},{"key":"2827_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1681\/ASN.2016080858","volume":"28","author":"MC Menon","year":"2017","unstructured":"Menon MC, Murphy B, Heeger PS. Moving biomarkers toward clinical implementation in kidney transplantation. J Am Soc Nephrol. 2017;28:735\u201347.","journal-title":"J Am Soc Nephrol"},{"key":"2827_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba2501","volume":"12","author":"JY Yang","year":"2020","unstructured":"Yang JY, Sarwal RD, Sigdel TK, et al. A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection. Sci Transl Med. 2020;12:eaba2501.","journal-title":"Sci Transl Med"},{"key":"2827_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/TP.0b013e318295ee5a","volume":"96","author":"TK Sigdel","year":"2013","unstructured":"Sigdel TK, Vitalone MJ, Tran TQ, et al. A rapid noninvasive assay for the detection of renal transplant injury. Transplantation. 2013;96:97\u2013101.","journal-title":"Transplantation"},{"key":"2827_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1681\/ASN.2015010062","volume":"27","author":"M Naesens","year":"2016","unstructured":"Naesens M, Lerut E, Emonds MP, et al. Proteinuria as a noninvasive marker for renal allograft histology and failure: an observational cohort study. J Am Soc Nephrol. 2016;27:281\u201392.","journal-title":"J Am Soc Nephrol"},{"key":"2827_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1681\/ASN.2020060850","volume":"32","author":"R El Fekih","year":"2021","unstructured":"El Fekih R, Hurley J, Tadigotla V, et al. Discovery and validation of a urinary exosome mRNA signature for the diagnosis of human kidney transplant rejection. J Am Soc Nephrol. 2021;32:994\u20131004.","journal-title":"J Am Soc Nephrol"},{"key":"2827_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.kint.2021.10.038","volume":"101","author":"J Ashcroft","year":"2022","unstructured":"Ashcroft J, Leighton P, Elliott TR, Hosgood SA, Nicholson ML, Kosmoliaptsis V. Extracellular vesicles in kidney transplantation: a state-of-the-art review. Kidney Int. 2022;101:485\u201397.","journal-title":"Kidney Int"},{"key":"2827_CR20","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/ndt\/gfac259","volume":"38","author":"J Burrello","year":"2023","unstructured":"Burrello J, Monticone S, Burrello A, et al. Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant. Nephrol Dial Transplant. 2023;38:764\u201377.","journal-title":"Nephrol Dial Transplant"},{"key":"2827_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/nep.13884","volume":"26","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Liu F, Guo L, et al. A novel urine cell\u2010free DNA preservation solution and its application in kidney transplantation. Nephrology. 2021;26:684\u201391.","journal-title":"Nephrology"},{"key":"2827_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphys.2025.100152","volume":"8","author":"PL Zhang","year":"2025","unstructured":"Zhang PL, Liu ML. From acute tubular injury to tubular repair and chronic kidney diseases\u2013KIM-1 as a promising biomarker for predicting renal tubular pathology. Curr Res Physiol. 2025;8:100152.","journal-title":"Curr Res Physiol"},{"key":"2827_CR23","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-2215a","volume":"9","author":"M Zhu","year":"2021","unstructured":"Zhu M, Chen Z, Wei Y, et al. The predictive value of urinary kidney injury molecular-1 for long-term graft function in kidney transplant patients: a prospective study. Ann Transl Med. 2021;9:244.","journal-title":"Ann Transl Med"},{"key":"2827_CR24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/01.tp.0000295982.78039.ef","volume":"84","author":"MM Van Timmeren","year":"2007","unstructured":"Van Timmeren MM, Vaidya VS, van Ree RM, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation. 2007;84:1625\u201330.","journal-title":"Transplantation"},{"key":"2827_CR25","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1111\/j.1600-6143.2006.01352.x","volume":"6","author":"CR Parikh","year":"2006","unstructured":"Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6:1639\u201345.","journal-title":"Am J Transplant"},{"key":"2827_CR26","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/j.1600-6143.2011.03680.x","volume":"11","author":"JA Jackson","year":"2011","unstructured":"Jackson JA, Kim EJ, Begley B, et al. Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. Am J Transplant. 2011;11:2228\u201334.","journal-title":"Am J Transplant"},{"key":"2827_CR27","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/j.1600-6143.2009.02645.x","volume":"9","author":"S Schaub","year":"2009","unstructured":"Schaub S, Nickerson P, Rush D, et al. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am J Transplant. 2009;9:1347\u201353.","journal-title":"Am J Transplant"},{"key":"2827_CR28","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1681\/ASN.2013080900","volume":"25","author":"M Matignon","year":"2014","unstructured":"Matignon M, Ding R, Dadhania DM, et al. Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction. J Am Soc Nephrol. 2014;25:1586\u201397.","journal-title":"J Am Soc Nephrol"},{"key":"2827_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1215555","volume":"369","author":"M Suthanthiran","year":"2013","unstructured":"Suthanthiran M, Schwartz JE, Ding R, et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med. 2013;369:20\u201331.","journal-title":"N Engl J Med"},{"key":"2827_CR30","doi-asserted-by":"publisher","first-page":"10655","DOI":"10.1038\/s41598-021-89758-4","volume":"11","author":"SB Mahbub","year":"2021","unstructured":"Mahbub SB, Nguyen LT, Habibalahi A, et al. Non-invasive assessment of exfoliated kidney cells extracted from urine using multispectral autofluorescence features. Sci Rep. 2021;11:10655.","journal-title":"Sci Rep"},{"key":"2827_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57524-7","volume":"10","author":"N Goerlich","year":"2020","unstructured":"Goerlich N, Brand HA, Langhans V, et al. Kidney transplant monitoring by urinary flow cytometry: biomarker combination of T cells, renal tubular epithelial cells, and podocalyxin-positive cells detects rejection. Sci Rep. 2020;10:796.","journal-title":"Sci Rep"},{"key":"2827_CR32","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.34067\/KID.0000000879","volume":"6","author":"HHL Wu","year":"2025","unstructured":"Wu HHL, Lang Y, Handley S, et al. Non-invasive assessment of urinary exfoliated proximal tubule cell multispectral autofluorescence may differentiate between causes of kidney transplant dysfunction. Kidney360. 2025;6:1853\u201362.","journal-title":"Kidney360"},{"key":"2827_CR33","doi-asserted-by":"crossref","unstructured":"Habibalahi A, Campbell JM, Mahbub SB, et al. moRphology-dEep Learning Imaging Cells (RELIC)-to Differentiate Between Normal and Pathological Kidney Exfoliated Cells. bioRxiv. 2022:2022\u201304","DOI":"10.1101\/2022.04.19.488847"},{"key":"2827_CR34","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","volume":"68","author":"B Gy\u00f6rgy","year":"2011","unstructured":"Gy\u00f6rgy B, Szab\u00f3 TG, P\u00e1szt\u00f3i M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68:2667\u201388.","journal-title":"Cell Mol Life Sci"},{"key":"2827_CR35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.23876\/j.krcp.23.286","volume":"44","author":"W Wang","year":"2024","unstructured":"Wang W, Haider CG, Wang Y, et al. Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejection. Kidney Res Clin Pract. 2024;44:705\u201325.","journal-title":"Kidney Res Clin Pract"},{"key":"2827_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57050482","volume":"57","author":"S Kant","year":"2021","unstructured":"Kant S, Brennan DC. Donor-derived cell-free DNA in kidney transplantation: origins, present and a look to the future. Medicina (Kaunas). 2021;57:482.","journal-title":"Medicina (Kaunas)"},{"key":"2827_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051480","volume":"9","author":"C Thongprayoon","year":"2020","unstructured":"Thongprayoon C, Vaitla P, Craici IM, et al. The use of donor-derived cell-free DNA for assessment of allograft rejection and injury status. J Clin Med. 2020;9:1480.","journal-title":"J Clin Med"},{"key":"2827_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116318","volume":"23","author":"M Lepoittevin","year":"2022","unstructured":"Lepoittevin M, Kerforne T, Pellerin L, Hauet T, Thuillier R. Molecular markers of kidney transplantation outcome: current omics tools and future developments. Int J Mol Sci. 2022;23:6318.","journal-title":"Int J Mol Sci"},{"key":"2827_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104635","volume":"93","author":"F Bienaim\u00e9","year":"2023","unstructured":"Bienaim\u00e9 F, Muorah M, Metzger M, et al. Combining robust urine biomarkers to assess chronic kidney disease progression. EBioMedicine. 2023;93:104635.","journal-title":"EBioMedicine"},{"key":"2827_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4068252","author":"M Neagu","year":"2016","unstructured":"Neagu M, Longo C, Ribero S. Omics landscape in disease biomarkers discovery. Dis Markers. 2016. https:\/\/doi.org\/10.1155\/2016\/4068252.","journal-title":"Dis Markers"},{"key":"2827_CR41","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1097\/TP.0b013e3181ffbadd","volume":"90","author":"C Afaneh","year":"2010","unstructured":"Afaneh C, Muthukumar T, Lubetzky M, et al. Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation. 2010;90:1381\u20137.","journal-title":"Transplantation"},{"key":"2827_CR42","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1111\/ajt.12426","volume":"13","author":"DE Hricik","year":"2013","unstructured":"Hricik DE, Nickerson P, Formica RN, et al. Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant. 2013;13:2634\u201344.","journal-title":"Am J Transplant"},{"key":"2827_CR43","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/ki.2008.459","volume":"74","author":"W Peng","year":"2008","unstructured":"Peng W, Chen J, Jiang Y, et al. Urinary fractalkine is a marker of acute rejection. Kidney Int. 2008;74:1454\u201360.","journal-title":"Kidney Int"},{"key":"2827_CR44","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1111\/ajt.12837","volume":"14","author":"TD Blydt-Hansen","year":"2014","unstructured":"Blydt-Hansen TD, Sharma A, Gibson IW, Mandal R, Wishart DS. Urinary metabolomics for noninvasive detection of borderline and acute T cell\u2013mediated rejection in children after kidney transplantation. Am J Transplant. 2014;14:2339\u201349.","journal-title":"Am J Transplant"},{"key":"2827_CR45","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/TP.0000000000000419","volume":"99","author":"TD Blydt-Hansen","year":"2015","unstructured":"Blydt-Hansen TD, Gibson IW, Gao A, Dufault B, Ho J. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation. Transplantation. 2015;99:797\u2013804.","journal-title":"Transplantation"},{"key":"2827_CR46","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1097\/FTD.0000000000000243","volume":"38","author":"U Christians","year":"2016","unstructured":"Christians U, Klawitter J, Klawitter J. Biomarkers in transplantation\u2014proteomics and metabolomics. Ther Drug Monit. 2016;38:S70\u20134.","journal-title":"Ther Drug Monit"},{"key":"2827_CR47","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/01.TP.0000064210.92444.B5","volume":"75","author":"R Ding","year":"2003","unstructured":"Ding R, Li B, Muthukumar T, et al. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts1. Transplantation. 2003;75:1307\u201312.","journal-title":"Transplantation"},{"key":"2827_CR48","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1681\/ASN.2004100836","volume":"16","author":"IA Hauser","year":"2005","unstructured":"Hauser IA, Spiegler S, Kiss E, et al. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-\u03b3 (MIG). J Am Soc Nephrol. 2005;16:1849\u201358.","journal-title":"J Am Soc Nephrol"},{"key":"2827_CR49","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/TP.0b013e31824fd892","volume":"93","author":"N Heyne","year":"2012","unstructured":"Heyne N, Kemmner S, Schneider C, Nadalin S, K\u00f6nigsrainer A, H\u00e4ring HU. Urinary neutrophil gelatinase-associated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients. Transplantation. 2012;93:1252\u20137.","journal-title":"Transplantation"},{"key":"2827_CR50","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1600-6143.2004.00354.x","volume":"4","author":"H Hu","year":"2004","unstructured":"Hu H, Aizenstein BD, Puchalski A, Burmania JA, Hamawy MM, Knechtle SJ. Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant. 2004;4:432\u20137.","journal-title":"Am J Transplant"},{"key":"2827_CR51","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1097\/01.TP.0000131157.19937.3F","volume":"77","author":"K Kotsch","year":"2004","unstructured":"Kotsch K, Mashreghi MF, Bold G, et al. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation. 2004;77:1866\u201375.","journal-title":"Transplantation"},{"key":"2827_CR52","doi-asserted-by":"publisher","first-page":"c19","DOI":"10.1159\/000070820","volume":"94","author":"SR Lederer","year":"2003","unstructured":"Lederer SR, Friedrich N, Regenbogen C, Getto R, Toepfer M, Sitter T. Non-invasive monitoring of renal transplant recipients: urinary excretion of soluble adhesion molecules and of the complement-split product C4d. Nephron Clin Pract. 2003;94:c19-26.","journal-title":"Nephron Clin Pract"},{"key":"2827_CR53","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJM200103293441301","volume":"344","author":"B Li","year":"2001","unstructured":"Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. New Engl J Med. 2001;344:947\u201354.","journal-title":"New Engl J Med"},{"key":"2827_CR54","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1111\/j.1600-6143.2011.03679.x","volume":"11","author":"JM Lorenzen","year":"2011","unstructured":"Lorenzen JM, Volkmann I, Fiedler J, et al. Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant. 2011;11:2221\u20137.","journal-title":"Am J Transplant"},{"key":"2827_CR55","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1097\/TP.0b013e3181914246","volume":"86","author":"RC Manfro","year":"2008","unstructured":"Manfro RC, Aquino-Dias EC, Joelsons G, Nogare AL, Carpio VN, Gon\u00e7alves LF. Noninvasive Tim-3 messenger RNA evaluation in renal transplant recipients with graft dysfunction. Transplantation. 2008;86:1869\u201374.","journal-title":"Transplantation"},{"key":"2827_CR56","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/sj.ki.5000343","volume":"69","author":"M Matz","year":"2006","unstructured":"Matz M, Beyer J, Wunsch D, et al. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short-and long-term graft function. Kidney Int. 2006;69:1683\u201390.","journal-title":"Kidney Int"},{"key":"2827_CR57","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1097\/01.TP.0000058230.91518.2F","volume":"75","author":"T Muthukumar","year":"2003","unstructured":"Muthukumar T, Ding R, Dadhania D, et al. Serine proteinase inhibitor-9, an endogenous blocker of granzyme B\/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation. 2003;75:1565\u201370.","journal-title":"Transplantation"},{"key":"2827_CR58","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1056\/NEJMoa051907","volume":"353","author":"T Muthukumar","year":"2005","unstructured":"Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. New Engl J Med. 2005;353:2342\u201351.","journal-title":"New Engl J Med"},{"key":"2827_CR59","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1053\/j.ajkd.2006.01.034","volume":"47","author":"WS Oetting","year":"2006","unstructured":"Oetting WS, Rogers TB, Krick TP, Matas AJ, Ibrahim HN. Urinary \u03b22-microglobulin is associated with acute renal allograft rejection. Am J Kidney Dis. 2006;47:898\u2013904.","journal-title":"Am J Kidney Dis"},{"key":"2827_CR60","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1600-6143.2007.01733.x","volume":"7","author":"E O\u2019Riordan","year":"2007","unstructured":"O\u2019Riordan E, Orlova TN, Podust VN, et al. Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am J Transplant. 2007;7:930\u201340.","journal-title":"Am J Transplant"},{"key":"2827_CR61","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1111\/ajt.13677","volume":"16","author":"M Rabant","year":"2016","unstructured":"Rabant M, Amrouche L, Morin L, et al. Early low urinary CXCL9 and CXCL10 might predict immunological quiescence in clinically and histologically stable kidney recipients. Am J Transplant. 2016;16:1868\u201381.","journal-title":"Am J Transplant"},{"key":"2827_CR62","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/j.1600-6143.2007.01795.x","volume":"7","author":"PG Renesto","year":"2007","unstructured":"Renesto PG, Ponciano VC, Cenedeze MA, C\u00e2mara NS, Pacheco-Silva A. High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am J Transplant. 2007;7:1661\u20135.","journal-title":"Am J Transplant"},{"key":"2827_CR63","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1600-6143.2006.01625.x","volume":"7","author":"M Seiler","year":"2007","unstructured":"Seiler M, Brabcova I, Viklicky O, et al. Heightened expression of the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy after kidney transplantation. Am J Transplant. 2007;7:423\u201333.","journal-title":"Am J Transplant"},{"key":"2827_CR64","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1074\/mcp.M113.030577","volume":"13","author":"TK Sigdel","year":"2014","unstructured":"Sigdel TK, Salomonis N, Nicora CD, et al. The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics. Mol Cell Proteomics. 2014;13:621\u201331.","journal-title":"Mol Cell Proteomics"},{"key":"2827_CR65","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/prca.201000109","volume":"5","author":"M Srivastava","year":"2011","unstructured":"Srivastava M, Eidelman O, Torosyan Y, Jozwik C, Mannon RB, Pollard HB. Elevated expression levels of ANXA11, integrins \u03b23 and \u03b13, and TNF\u2010\u03b1 contribute to a candidate proteomic signature in urine for kidney allograft rejection. Proteomics Clin Appl. 2011;5:311\u201321.","journal-title":"Proteomics Clin Appl"},{"key":"2827_CR66","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1681\/ASN.2015010107","volume":"27","author":"K Suhre","year":"2016","unstructured":"Suhre K, Schwartz JE, Sharma VK, et al. Urine metabolite profiles predictive of human kidney allograft status. J Am Soc Nephrol. 2016;27:626\u201336.","journal-title":"J Am Soc Nephrol"},{"key":"2827_CR67","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/j.1523-1755.2004.00663.x","volume":"65","author":"RR Tatapudi","year":"2004","unstructured":"Tatapudi RR, Muthukumar T, Dadhania D, et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int. 2004;65:2390\u20137.","journal-title":"Kidney Int"},{"key":"2827_CR68","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/ki.2010.274","volume":"78","author":"SM Van Ham","year":"2010","unstructured":"Van Ham SM, Heutinck KM, Jorritsma T, et al. Urinary granzyme A mRNA is a biomarker to diagnose subclinical and acute cellular rejection in kidney transplant recipients. Kidney Int. 2010;78:1033\u201340.","journal-title":"Kidney Int"},{"key":"2827_CR69","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003076","volume":"95","author":"TY Koo","year":"2016","unstructured":"Koo TY, Jeong JC, Lee Y, et al. Pre-transplant evaluation of donor urinary biomarkers can predict reduced graft function after deceased donor kidney transplantation. Medicine. 2016;95:e3076.","journal-title":"Medicine"},{"key":"2827_CR70","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13202","volume":"22","author":"CM Mincham","year":"2018","unstructured":"Mincham CM, Gibson IW, Sharma A, et al. Evolution of renal function and urinary biomarker indicators of inflammation on serial kidney biopsies in pediatric kidney transplant recipients with and without rejection. Pediatr Transplant. 2018;22:e13202.","journal-title":"Pediatr Transplant"},{"key":"2827_CR71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1681\/ASN.0000000000000260","volume":"35","author":"M Raynaud","year":"2024","unstructured":"Raynaud M, Al-Awadhi S, Louis K, et al. Prognostic biomarkers in kidney transplantation: a systematic review and critical appraisal. J Am Soc Nephrol. 2024;35:177\u201388.","journal-title":"J Am Soc Nephrol"},{"key":"2827_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091555","volume":"17","author":"A Tebani","year":"2016","unstructured":"Tebani A, Afonso C, Marret S, Bekri S. Omics-based strategies in precision medicine: toward a paradigm shift in inborn errors of metabolism investigations. Int J Mol Sci. 2016;17:1555.","journal-title":"Int J Mol Sci"},{"key":"2827_CR73","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bmhime.2017.11.030","volume":"74","author":"H Quezada","year":"2017","unstructured":"Quezada H, Guzm\u00e1n-Ortiz AL, D\u00edaz-S\u00e1nchez H, Valle-Rios R, Aguirre-Hern\u00e1ndez J. Omics-based biomarkers: current status and potential use in the clinic. Bolet\u00edn M\u00e9dico Del Hospital Infantil de M\u00e9xico (English Edition). 2017;74:219\u201326.","journal-title":"Bolet\u00edn M\u00e9dico Del Hospital Infantil de M\u00e9xico (English Edition)"},{"key":"2827_CR74","volume":"2011","author":"B Kaeffer","year":"2011","unstructured":"Kaeffer B. Survival of exfoliated epithelial cells: a delicate balance between anoikis and apoptosis. J Biotechnol Biomed. 2011;2011:534139.","journal-title":"J Biotechnol Biomed"},{"key":"2827_CR75","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1440-1797.2012.01619.x","volume":"17","author":"LA Ni","year":"2012","unstructured":"Ni LA, Saleem M, Mathieson PW. Podocyte culture: tricks of the trade. Nephrology. 2012;17:525\u201331.","journal-title":"Nephrology"},{"key":"2827_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147610","volume":"23","author":"HHL Wu","year":"2022","unstructured":"Wu HHL, Goldys EM, Pollock CA, Saad S. Exfoliated kidney cells from urine for early diagnosis and prognostication of CKD: the way of the future? Int J Mol Sci. 2022;23:7610.","journal-title":"Int J Mol Sci"},{"key":"2827_CR77","first-page":"70","volume":"37","author":"S Mackensen-Haen","year":"1992","unstructured":"Mackensen-Haen S, Bohle A, Christensen J, Wehrmann M, Kendziorra H, Kokot F. The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clin Nephrol. 1992;37:70\u20137.","journal-title":"Clin Nephrol"},{"key":"2827_CR78","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1681\/ASN.2019070712","volume":"31","author":"JA Hollywood","year":"2020","unstructured":"Hollywood JA, Przepiorski A, D\u2019Souza RF, et al. Use of human induced pluripotent stem cells and kidney organoids to develop a cysteamine\/mTOR inhibition combination therapy for cystinosis. J Am Soc Nephrol. 2020;31:962\u201382.","journal-title":"J Am Soc Nephrol"},{"key":"2827_CR79","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/ndt\/gfw002","volume":"31","author":"J Perez-Hernandez","year":"2016","unstructured":"Perez-Hernandez J, Olivares MD, Forner MJ, Chaves FJ, Cortes R, Redon J. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis. Nephrol Dial Transplant. 2016;31:780\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2827_CR80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/kisup.2014.2","volume":"4","author":"AA Eddy","year":"2014","unstructured":"Eddy AA. Overview of the cellular and molecular basis of kidney fibrosis. Kidney Int Suppl. 2014;4(1):2\u20138.","journal-title":"Kidney Int Suppl"},{"key":"2827_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.02.1290","volume":"9","author":"HHL Wu","year":"2024","unstructured":"Wu HHL, Nguyen LT, Venkatesha V, Goldys E, Pollock C, Saad S. WCN24-213 diabetic kidney disease and number of urinary exfoliated proximal tubule cells: is there a link? Kidney Int Rep. 2024;9:S613.","journal-title":"Kidney Int Rep"},{"key":"2827_CR82","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001501","volume":"8","author":"T Marumo","year":"2020","unstructured":"Marumo T, Hoshino J, Kawarazaki W, et al. Methylation pattern of urinary DNA as a marker of kidney function decline in diabetes. BMJ Open Diabetes Res Care. 2020;8:e001501.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2827_CR83","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/239231a0","volume":"239","author":"GR Sutherland","year":"1972","unstructured":"Sutherland GR, Bain AD. Culture of cells from the urine of newborn children. Nature. 1972;239:231.","journal-title":"Nature"},{"key":"2827_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/362562","volume":"2015","author":"F Oliveira Arcolino","year":"2015","unstructured":"Oliveira Arcolino F, Tort Piella A, Papadimitriou E, et al. Human urine as a noninvasive source of kidney cells. Stem Cells Int. 2015;2015:362562.","journal-title":"Stem Cells Int"},{"key":"2827_CR85","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1681\/ASN.V133630","volume":"13","author":"MA Saleem","year":"2002","unstructured":"Saleem MA, O\u2019Hare MJ, Reiser J, et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol. 2002;13:630\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"2827_CR86","doi-asserted-by":"publisher","first-page":"F557","DOI":"10.1152\/ajprenal.00509.2009","volume":"298","author":"T Sakairi","year":"2010","unstructured":"Sakairi T, Abe Y, Kajiyama H, et al. Conditionally immortalized human podocyte cell lines established from urine. Am J Physiol Renal Physiol. 2010;298:F557\u201367.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2827_CR87","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1681\/ASN.2020050757","volume":"32","author":"A Abedini","year":"2021","unstructured":"Abedini A, Zhu YO, Chatterjee S, et al. Urinary single-cell profiling captures the cellular diversity of the kidney. J Am Soc Nephrol. 2021;32:614\u201327.","journal-title":"J Am Soc Nephrol"},{"key":"2827_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061413","volume":"10","author":"T Bondue","year":"2021","unstructured":"Bondue T, Arcolino FO, Veys KR, et al. Urine-derived epithelial cells as models for genetic kidney diseases. Cells. 2021;10:1413.","journal-title":"Cells"},{"key":"2827_CR89","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cca.2021.10.017","volume":"523","author":"L Zeng","year":"2021","unstructured":"Zeng L, Szeto CC. Urinary podocyte markers in kidney diseases. Clin Chim Acta. 2021;523:315\u201324.","journal-title":"Clin Chim Acta"},{"key":"2827_CR90","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae069.1364","volume":"39","author":"HHL Wu","year":"2024","unstructured":"Wu HHL, Lang Y, Knab A, et al. #328 Non-invasive assessment of urinary exfoliated proximal tubule cells using multispectral autofluorescence imaging features for early detection of CKD. Nephrol Dial Transplant. 2024;39:gfae069-1364.","journal-title":"Nephrol Dial Transplant"},{"key":"2827_CR91","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbamcr.2015.09.030","volume":"1863","author":"ME Gosnell","year":"2016","unstructured":"Gosnell ME, Anwer AG, Cassano JC, Sue CM, Goldys EM. Functional hyperspectral imaging captures subtle details of cell metabolism in olfactory neurosphere cells, disease-specific models of neurodegenerative disorders. Biochim Biophys Acta Mol Cell Res. 2016;1863:56\u201363.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2827_CR92","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jtos.2019.03.003","volume":"17","author":"A Habibalahi","year":"2019","unstructured":"Habibalahi A, Bala C, Allende A, Anwer AG, Goldys EM. Novel automated non-invasive detection of ocular surface squamous neoplasia using multispectral autofluorescence imaging. Ocul Surf. 2019;17:540\u201350.","journal-title":"Ocul Surf"},{"key":"2827_CR93","doi-asserted-by":"publisher","first-page":"23453","DOI":"10.1038\/srep23453","volume":"6","author":"ME Gosnell","year":"2016","unstructured":"Gosnell ME, Anwer AG, Mahbub SB, et al. Quantitative non-invasive cell characterisation and discrimination based on multispectral autofluorescence features. Sci Rep. 2016;6:23453.","journal-title":"Sci Rep"},{"key":"2827_CR94","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.celrep.2020.01.058","volume":"30","author":"MJ Bertoldo","year":"2020","unstructured":"Bertoldo MJ, Listijono DR, Ho WH, et al. NAD+ repletion rescues female fertility during reproductive aging. Cell Rep. 2020;30:1670\u201381.","journal-title":"Cell Rep"},{"key":"2827_CR95","doi-asserted-by":"publisher","first-page":"141343","DOI":"10.1109\/ACCESS.2019.2942959","volume":"7","author":"A Habibalahi","year":"2019","unstructured":"Habibalahi A, Allende A, Bala C, Anwer AG, Mukhopadhyay S, Goldys EM. Optimized autofluorescence spectral signature for non-invasive diagnostics of ocular surface squamous neoplasia (OSSN). IEEE Access. 2019;7:141343\u201351.","journal-title":"IEEE Access"},{"key":"2827_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101561","volume":"34","author":"A Habibalahi","year":"2020","unstructured":"Habibalahi A, Moghari MD, Campbell JM, et al. Non-invasive real-time imaging of reactive oxygen species (ROS) using auto-fluorescence multispectral imaging technique: A novel tool for redox biology. Redox Biol. 2020;34:101561.","journal-title":"Redox Biol"},{"key":"2827_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40942-7","volume":"9","author":"SB Mahbub","year":"2019","unstructured":"Mahbub SB, Guller A, Campbell JM, et al. Non-invasive monitoring of functional state of articular cartilage tissue with label-free unsupervised hyperspectral imaging. Sci Rep. 2019;9:4398.","journal-title":"Sci Rep"},{"key":"2827_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121630","volume":"12","author":"V Pizzuti","year":"2023","unstructured":"Pizzuti V, Donadei C, Balducelli E, et al. Urine-derived renal epithelial cells (URECs) from transplanted kidneys as a promising immunomodulatory cell population. Cells. 2023;12:1630.","journal-title":"Cells"},{"key":"2827_CR99","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1053\/j.ajkd.2016.03.004","volume":"67","author":"MA Lusco","year":"2016","unstructured":"Lusco MA, Fogo AB, Najafian B, Alpers CE. AJKD atlas of renal pathology: acute T-cell\u2013mediated rejection. Am J Kidney Dis. 2016;67:e29-30.","journal-title":"Am J Kidney Dis"},{"key":"2827_CR100","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/imr.12146","volume":"258","author":"DN Mori","year":"2014","unstructured":"Mori DN, Kreisel D, Fullerton JN, Gilroy DW, Goldstein DR. Inflammatory triggers of acute rejection of organ allografts. Immunol Rev. 2014;258:132\u201344.","journal-title":"Immunol Rev"},{"key":"2827_CR101","doi-asserted-by":"publisher","first-page":"5763430","DOI":"10.1155\/2019\/5763430","volume":"2019","author":"J Li","year":"2019","unstructured":"Li J, Li C, Zhuang Q, et al. The evolving roles of macrophages in organ transplantation. J Immunol Res. 2019;2019:5763430.","journal-title":"J Immunol Res"},{"key":"2827_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.582939","volume":"11","author":"F Ordikhani","year":"2020","unstructured":"Ordikhani F, Pothula V, Sanchez-Tarjuelo R, Jordan S, Ochando J. Macrophages in organ transplantation. Front Immunol. 2020;11:582939.","journal-title":"Front Immunol"},{"key":"2827_CR103","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1378\/chest.128.4.2847","volume":"128","author":"N Gill","year":"2005","unstructured":"Gill N, Nally JV Jr., Fatica RA. Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management. Chest. 2005;128:2847\u201363.","journal-title":"Chest"},{"key":"2827_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trre.2007.09.004","volume":"22","author":"S Bedi","year":"2008","unstructured":"Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev. 2008;22:1\u20135.","journal-title":"Transplant Rev"},{"key":"2827_CR105","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4:481\u2013508.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2827_CR106","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40472-021-00336-z","volume":"8","author":"IR Schwantes","year":"2021","unstructured":"Schwantes IR, Axelrod DA. Technology-enabled care and artificial intelligence in kidney transplantation. Curr Transplant Rep. 2021;8:235\u201340.","journal-title":"Curr Transplant Rep"},{"key":"2827_CR107","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5500\/wjt.v11.i7.277","volume":"11","author":"N Seyahi","year":"2021","unstructured":"Seyahi N, Ozcan SG. Artificial intelligence and kidney transplantation. World J Transplant. 2021;11:277\u201389.","journal-title":"World J Transplant"},{"key":"2827_CR108","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semnephrol.2022.01.007","volume":"42","author":"KM Yatim","year":"2022","unstructured":"Yatim KM, Azzi JR. Novel biomarkers in kidney transplantation. Semin Nephrol. 2022;42:2\u201313.","journal-title":"Semin Nephrol"},{"key":"2827_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-015-0206-y","volume":"15","author":"A Decruyenaere","year":"2015","unstructured":"Decruyenaere A, Decruyenaere P, Peeters P, Vermassen F, Dhaene T, Couckuyt I. Prediction of delayed graft function after kidney transplantation: comparison between logistic regression and machine learning methods. BMC Med Inform Decis Mak. 2015;15:83.","journal-title":"BMC Med Inform Decis Mak"},{"key":"2827_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75473-z","volume":"10","author":"S Kawakita","year":"2020","unstructured":"Kawakita S, Beaumont JL, Jucaud V, Everly MJ. Personalized prediction of delayed graft function for recipients of deceased donor kidney transplants with machine learning. Sci Rep. 2020;10:18409.","journal-title":"Sci Rep"},{"key":"2827_CR111","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KGM, Dhiman P, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.","journal-title":"BMJ"},{"key":"2827_CR112","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1038\/s41591-025-03953-8","volume":"31","author":"V Sounderajah","year":"2025","unstructured":"Sounderajah V, Guni A, Liu X, Collins GS, et al. T STARD-AI Steering Committee the STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence. Nat Med. 2025;31:3283\u20139.","journal-title":"Nat Med"},{"key":"2827_CR113","doi-asserted-by":"publisher","first-page":"M3164","DOI":"10.1136\/bmj.m3164","volume":"370","author":"X Liu","year":"2020","unstructured":"Liu X, Rivera SC, Moher D, Calvert MJ, Denniston AK. SPIRIT-AI and CONSORT-AI Working Group Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. BMJ. 2020;370:M3164.","journal-title":"BMJ"},{"key":"2827_CR114","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3210","volume":"370","author":"SC Rivera","year":"2020","unstructured":"Rivera SC, Liu X, Chan A-W, et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension. BMJ. 2020;370:m3210.","journal-title":"BMJ"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02827-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:02:29Z","timestamp":1780732949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02827-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":114,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2827"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02827-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors do not have any conflict of interest to declare for the work presented in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}